BioCentury
ARTICLE | Clinical News

Avioq HTLV-I/II Microelisa System regulatory update

September 2, 2013 7:00 AM UTC

Avioq said Health Canada approved in July its Avioq HTLV-I/II Microelisa System to detect antibodies to human T lymphotropic virus Type I (HTLV-I) and Type II (HTLV-II) in serum or plasma. The enzyme-...